Hepatic Adverse Effects and Genetic Polymorphisms of NAT2 and CYP2C9. Precision Medicine Communications, [S. l.], v. 1, n. 1, p. 05–07, 2021. DOI: 10.55627/pmc.001.01.0072. Disponível em: https://rootspress.org/journals/index.php/PMC/article/view/72. Acesso em: 8 may. 2026.